University of Alabama at Birmingham-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:University of Alabama at Birmingham - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013496
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:68
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
University of Alabama at Birmingham (UAB), a subsidiary of University of Alabama System is an educational university that offers undergraduate and graduate programs. The university provides graduate programs in arts and sciences, health professions, medicine, nursing, business, dentistry, education, engineering, optometry and public health areas. It also provides student affair programs that include career and professional development, dining, housing and residence life, hill student center, student life, one stop student services, campus recreation, disability support services, and student health and wellness. The university also offers resources for researchers such as research portal, clinical trials, compliance training and post-doctoral training. UAB is headquartered in Birmingham, Alabama, the US.

University of Alabama at Birmingham – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
University of Alabama at Birmingham, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
University of Alabama at Birmingham, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
University of Alabama at Birmingham, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
University of Alabama at Birmingham, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9
University of Alabama at Birmingham, Medical Devices Deals, 2011 to YTD 2017 10
University of Alabama at Birmingham, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
University of Alabama at Birmingham, Pharmaceuticals & Healthcare, Deal Details 13
Partnerships 13
CRISPR Enters into Agreement with University of Alabama 13
Diamyd Medical Enter into Partnership with Janssen R&D, JDRF and UAB 14
Proton International Enters into Agreement with University of Alabama at Birmingham 15
Spotlight Innovation Enters into Research Agreement with University of Alabama at Birmingham 16
Synedgen Enters Into Research Agreement With Cincinnati Children’s Hospital Medical Center And University Of Alabama 17
Licensing Agreements 18
IURTC and University of Alabama at Birmingham Enter into Licensing Agreement with La Jolla Pharma 18
Incysus Enters into Licensing Agreement with Emory University, Children’s Hospital of Atlanta and University of Alabama at Birmingham 19
University Of Alabama Enters Into Licensing Agreement With Illumina 20
LipimetiX Amends its Licensing Agreement with UAB Research Foundation 21
Janus Developments Enters Into Licensing Agreement With UAB And ICMAB 22
Janus Developments Enters Into Licensing Agreement With University of Alabama at Birmingham 23
University of Alabama at Birmingham – Key Competitors 24
University of Alabama at Birmingham – Key Employees 25
University of Alabama at Birmingham – Locations And Subsidiaries 26
Head Office 26
Other Locations & Subsidiaries 26
Recent Developments 27
Legal and Regulatory 27
Sep 01, 2016: NSF approves UAB Center for Health Organization Transformation 27
Aug 10, 2016: New guidelines published for physicians treating patients with kidney stones 28
Government and Public Interest 29
Nov 16, 2017: UAB physician-scientist receives Komen grant to conduct HER2-positive breast cancer research 29
Nov 16, 2017: First Ever Effective Intervention Against Dementia Shown in Large Study 30
Nov 07, 2017: Targeting a microRNA shows potential to enhance effectiveness of diabetes drugs 32
Oct 26, 2017: Multi-site study will examine cognitive behavior therapy for traumatic brain injury-induced seizures 34
Oct 26, 2017: Study shows brain structures make some people resilient to Alzheimer’s disease 35
Oct 16, 2017: Plant-based diet converts breast cancer in mice from lethal to treatable form 37
Oct 13, 2017: CRISPR Therapeutics Awarded Grant From Friedreich’s Ataxia Research Alliance to Collaborate with University of Alabama at Birmingham on Gene-edited Treatments for Friedrich’s Ataxia 39
Oct 09, 2017: Translational researchers at UAB received a $6.5 million grant to further investigate gout and associated diseases 40
Oct 04, 2017: Care could improve for dialysis patients with development of bionanomatrix gel with $2 million grant 41
Oct 02, 2017: Preventing autoimmune disease after a viral infection 43
Aug 09, 2017: Small molecule inhibitor prevents or impedes tooth cavities in a preclinical model 44
Jul 11, 2017: Dry eye relief progresses with new guidelines and expansion of UAB’s Dry Eye Relief Clinic 46
Sep 07, 2016: Stealth pig cells may hold the key to treating diabetes in humans 47
Aug 23, 2016: Discovery of mechanism that alters neural excitability offers window into neuropsychiatric disease 49
Aug 22, 2016: UAB study finds potential treatment target for Guillain-Barré syndrome 50
Aug 17, 2016: Advancements in aging research target multiple age-related diseases 52
Jul 28, 2016: Acute kidney injury identifiable in preterm infants 54
Jul 21, 2016: Precision medicine clinical trial available for cancer patients at UAB 55
Jul 14, 2016: UAB researchers awarded $11.5 million to study asymptomatic congenital CMV and neonatal HSV 56
Jul 13, 2016: UAB researcher receives funding for rheumatology study 57
Jul 06, 2016: HudsonAlpha and UAB awarded NIH training grant 58
Jul 06, 2016: BCRFA announces funding opportunity for collaborative breast cancer research 59
Jul 05, 2016: Parkinson’s disease biomarker found in patient urine samples 60
May 16, 2016: HIV vaccine design should adapt as HIV virus mutates 62
Feb 18, 2016: Surgery and stenting safe, effective lowering long-term risk of stroke 63
Feb 15, 2016: Cell marker found for leukemia-initiating capacity in chronic myelogenous leukemia 64
Feb 12, 2016: REGARDS data show diabetics who use verapamil have lower glucose levels 66
Product News 67
Feb 01, 2017: Researchers develop best-yet cell culture system for age-related macular degeneration 67
Appendix 68
Methodology 68
About GlobalData 68
Contact Us 68
Disclaimer 68

List of Tables
University of Alabama at Birmingham, Pharmaceuticals & Healthcare, Key Facts 2
University of Alabama at Birmingham, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
University of Alabama at Birmingham, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
University of Alabama at Birmingham, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
University of Alabama at Birmingham, Deals By Therapy Area, 2011 to YTD 2017 9
University of Alabama at Birmingham, Medical Devices Deals, 2011 to YTD 2017 10
University of Alabama at Birmingham, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
CRISPR Enters into Agreement with University of Alabama 13
Diamyd Medical Enter into Partnership with Janssen R&D, JDRF and UAB 14
Proton International Enters into Agreement with University of Alabama at Birmingham 15
Spotlight Innovation Enters into Research Agreement with University of Alabama at Birmingham 16
Synedgen Enters Into Research Agreement With Cincinnati Children’s Hospital Medical Center And University Of Alabama 17
IURTC and University of Alabama at Birmingham Enter into Licensing Agreement with La Jolla Pharma 18
Incysus Enters into Licensing Agreement with Emory University, Children’s Hospital of Atlanta and University of Alabama at Birmingham 19
University Of Alabama Enters Into Licensing Agreement With Illumina 20
LipimetiX Amends its Licensing Agreement with UAB Research Foundation 21
Janus Developments Enters Into Licensing Agreement With UAB And ICMAB 22
Janus Developments Enters Into Licensing Agreement With University of Alabama at Birmingham 23
University of Alabama at Birmingham, Key Competitors 24
University of Alabama at Birmingham, Key Employees 25
University of Alabama at Birmingham, Subsidiaries 26

★海外企業調査レポート[University of Alabama at Birmingham-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Vetoquinol SA (VETO):企業の財務・戦略的SWOT分析
    Summary Vetoquinol SA (Vetoquinol) is a veterinary pharmaceutical company that develops, produces and distributes veterinary drugs and non-medicinal products. The company provides pain management, anti-infective, hygiene and care, pest control, behavior, internal medicine, reproduction, behaviour an …
  • China Energy Conservation and Environmental Protection Group-エネルギー分野:企業M&A・提携分析
    Summary China Energy Conservation and Environmental Protection Group (CECEP) is a clean technology company that offers energy conservation, emission reduction and environment protection services. The company provides clean energy, energy saving, environmental protection, integrated services and reso …
  • Moximed Inc:医療機器:M&Aディール及び事業提携情報
    Summary Moximed Inc (Moximed), formerly ExploraMed NC4, Inc. focuses to develop unicompartmental load absorber implants for patients with painful knee osteoarthritis (OA). The company provides Atlas Knee System, an implantable knee joint unloader which works as a shock absorber for pre-arthroplasty …
  • Sony Mobile Communications AB.:企業の戦略的SWOT分析
    Sony Mobile Communications AB. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Kyorin Pharmaceutical Co Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Kyorin Pharmaceutical Co Ltd (Kyorin), a subsidiary of Kyorin Holdings Inc, is a pharmaceutical company that manufactures and markets prescription medicines. The company offers ethical drugs including mucodyne, kipres, desalex, flutiform, pentasa, ketas and uritos. Its ketas product is a pho …
  • CollPlant Ltd:医療機器:M&Aディール及び事業提携情報
    Summary CollPlant Ltd (CollPlant) is a regenerative medicine company that develops and commercializes tissue repair products. The company’s product categories include orthobiologics, wound care, and pipeline products. Its orthobiologics products comprise VergenixSTR and VergenixBVF. CollPlant’s woun …
  • CSB Bancorp Inc (CSBB):企業の財務・戦略的SWOT分析
    CSB Bancorp Inc (CSBB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • The Bank of Yokohama, Ltd.:企業の戦略・SWOT・財務情報
    The Bank of Yokohama, Ltd. - Strategy, SWOT and Corporate Finance Report Summary The Bank of Yokohama, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Laboratory Corporation of America Holdings:企業のM&A・事業提携・投資動向
    Laboratory Corporation of America Holdings - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Laboratory Corporation of America Holdings Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detai …
  • Hurricane Energy Plc (HUR):石油・ガス:M&Aディール及び事業提携情報
    Summary Hurricane Energy Plc (Hurricane) is an oil and gas exploration and development company that discovers and develops oil from fractured basement reservoirs. The company provides exploration properties such as lancaster basement prospect, whirlwind basement discovery, lincoln basement prospect, …
  • Alamo Group, Inc.:戦略・SWOT・企業財務分析
    Alamo Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Alamo Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • FleetCor Technologies Inc:企業の戦略・SWOT・財務分析
    FleetCor Technologies Inc - Strategy, SWOT and Corporate Finance Report Summary FleetCor Technologies Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Imperial Oil Ltd (IMO):石油・ガス:M&Aディール及び事業提携情報
    Summary Imperial Oil Ltd (Imperial Oil), a subsidiary of Exxon Mobil Corporation, is an integrated energy company. It is present across the value chain in petroleum industry including the exploration, production and sale of crude oil and natural gas. The company explores for and produces crude oil, …
  • CitiPower and Powercor:企業の戦略的SWOT分析
    CitiPower and Powercor - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Redcape Hotel Group:企業の戦略・SWOT・財務分析
    Redcape Hotel Group - Strategy, SWOT and Corporate Finance Report Summary Redcape Hotel Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Maruho Co Ltd:企業の戦略的SWOT分析
    Maruho Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Commonwealth Bank of Australia:企業の戦略・SWOT・財務情報
    Commonwealth Bank of Australia - Strategy, SWOT and Corporate Finance Report Summary Commonwealth Bank of Australia - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Valeo SA (FR):企業の財務・戦略的SWOT分析
    Valeo SA (FR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • Largan Precision Co Ltd (3008):企業の財務・戦略的SWOT分析
    Largan Precision Co Ltd (3008) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Bank of Ayudhya Public Co Ltd (BAY):企業の財務・戦略的SWOT分析
    Bank of Ayudhya Public Co Ltd (BAY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆